The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chamberlain, M. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.131 · Cited by 116
RetractedGefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Self-citationRosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Mitsudomi, T., Morita, S., Yatabe, Y., Negoro, S., Okamoto, I., Tsurutani, J., Seto, T., Satouchi, M., Tada, H., Hirashima, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70364-x · Cited by 4,090
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Jänne, P. A., Yang, J. C.-H., Kim, D.-W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M.-J., Kim, S.-W., Su, W.-C., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411817 · Cited by 2,116
Self-citationYang, J. C.-H., Wu, Y.-L., Schuler, M., Sebastian, M., Popat, S., Yamamoto, N., Zhou, C., Hu, C.-P., O'Byrne, K., Feng, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71173-8 · Cited by 1,574
Self-citationAparicio, A., & Chamberlain, M. C. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0081-7 · Cited by 487
Welsh, J. W., Komaki, R., Amini, A., Munsell, M. F., Unger, W., Allen, P. K., Chang, J. Y., Wefel, J. S., McGovern, S. L., Garland, L. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1174 · Cited by 395
Grommes, C., Oxnard, G. R., Kris, M. G., Miller, V. A., Pao, W., Holodny, A. I., Clarke, J. L., & Lassman, A. B. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor121 · Cited by 349
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
Chamberlain, M., Le Rhun, E., & Taillibert, S. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.111304 · Cited by 338
Togashi, Y., Masago, K., Masuda, S., Mizuno, T., Fukudo, M., Ikemi, Y., Sakamori, Y., Nagai, H., Kim, Y. H., Katsura, T., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1929-4 · Cited by 282
Morris, P. G., Reiner, A. S., Szenberg, O. R., Clarke, J. L., Panageas, K. S., Perez, H. R., Kris, M. G., Chan, T. A., DeAngelis, L. M., & Omuro, A. M. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182398e4f · Cited by 280
Gleissner, B., & Chamberlain, M. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70443-4 · Cited by 277
Hoffknecht, P., Tufman, A., Wehler, T., Pelzer, T., Wiewrodt, R., Schütz, M., Serke, M., Stöhlmacher-Williams, J., Märten, A., Maria Huber, R., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000380 · Cited by 252
Omuro, A. M. P., Kris, M. G., Miller, V. A., Franceschi, E., Shah, N., Milton, D. T., & Abrey, L. E. (2005) · Cancer · doi:10.1002/cncr.21033 · Cited by 228
Clarke, J. L., Pao, W., Wu, N., Miller, V. A., & Lassman, A. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0128-6 · Cited by 214 · cited 1×
“If the concentration of TKIs in plasma is high enough, it may be more likely to reach a therapeutic concentration in the CSF, which is why high-dose TKIs were suggested.(18,21,32) It has been reported that the concentration of erlotinib penetrating into the CSF was higher than that of gefitinib.”
BackgroundLee, S. J., Lee, J.-I., Nam, D.-H., Ahn, Y. C., Han, J. H., Sun, J.-M., Ahn, J. S., Park, K., & Ahn, M.-J. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182773f21 · Cited by 194
Liao, B.-C., Lee, J.-H., Lin, C.-C., Chen, Y.-F., Chang, C.-H., Ho, C.-C., Shih, J.-Y., Yu, C.-J., & Yang, J. C.-H. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000669 · Cited by 185
Self-citationFrequent EGFR mutations in brain metastases of lung adenocarcinoma
Matsumoto, S., Takahashi, K., Iwakawa, R., Matsuno, Y., Nakanishi, Y., Kohno, T., Shimizu, E., & Yokota, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21940 · Cited by 181
Hata, A., Katakami, N., Yoshioka, H., Takeshita, J., Tanaka, K., Nanjo, S., Fujita, S., Kaji, R., Imai, Y., Monden, K., et al. (2013) · Cancer · doi:10.1002/cncr.28364 · Cited by 178
Park, J. H., Kim, Y. J., Lee, J.-O., Lee, K.-W., Kim, J. H., Bang, S.-M., Chung, J.-H., Kim, J. S., & Lee, J. S. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.022 · Cited by 174
Yang, J.-J., Chen, H.-J., Yan, H.-H., Zhang, X.-C., Zhou, Q., Su, J., Wang, Z., Xu, C.-R., Huang, Y.-S., Wang, B.-C., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.016 · Cited by 164
Self-citationZeng, Q., Wang, J., Cheng, Z., Chen, K., Johnström, P., Varnäs, K., Li, D. Y., Yang, Z. F., & Zhang, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01073 · Cited by 161
Leptomeningeal metastasis: Clinical experience of 519 cases
Hyun, J., Jeong, I. H., Joung, A., Cho, H. J., Kim, S., & Kim, H. J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.021 · Cited by 153
Kuiper, J. L., Hendriks, L. E. L., van der Wekken, A. J., de Langen, A. J., Bahce, I., Thunnissen, E., Heideman, D. A. M., Berk, Y., Buijs, E. J. M., Speel, E. M., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.05.023 · Cited by 137
Umemura, S., Tsubouchi, K., Yoshioka, H., Hotta, K., Takigawa, N., Fujiwara, K., Horita, N., Segawa, Y., Hamada, N., Takata, I., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.002 · Cited by 135
Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma
Zhao, J., Chen, M., Zhong, W., Zhang, L., Li, L., Xiao, Y., Nie, L., Hu, P., & Wang, M. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.06.004 · Cited by 123
Lee, E., Keam, B., Kim, D., Kim, T. M., Lee, S., Chung, D. H., & Heo, D. S. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318294c8e8 · Cited by 123
Zeng, Y.-D., Liao, H., Qin, T., Zhang, L., Wei, W.-D., Liang, J.-Z., Xu, F., Dinglin, X.-X., Ma, S.-X., & Chen, L.-K. (2015) · Oncotarget · doi:10.18632/oncotarget.3187 · Cited by 115
Tan, C.-S., Cho, B.-C., & Soo, R. A. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.01.003 · Cited by 105
Masuda, T., Hattori, N., Hamada, A., Iwamoto, H., Ohshimo, S., Kanehara, M., Ishikawa, N., Fujitaka, K., Haruta, Y., Murai, H., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1555-6 · Cited by 98
Management of leptomeningeal metastases: Prognostic factors and associated outcomes
Brower, J. V., Saha, S., Rosenberg, S. A., Hullett, C. R., & Robins, H. I. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.012 · Cited by 89
Riess, J. W., Nagpal, S., Iv, M., Zeineh, M., Gubens, M. A., Ramchandran, K. J., Neal, J. W., & Wakelee, H. A. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.12.009 · Cited by 81
Kawamura, T., Hata, A., Takeshita, J., Fujita, S., Hayashi, M., Tomii, K., & Katakami, N. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2759-y · Cited by 79
Nanjo, S., Ebi, H., Arai, S., Takeuchi, S., Yamada, T., Mochizuki, S., Okada, Y., Nakada, M., Murakami, T., & Yano, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6758 · Cited by 58
Yang, H., Yang, X., Zhang, Y., Liu, X., Deng, Q., Zhao, M., Xu, X., & He, J. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0326-9 · Cited by 29
Gong, L., Xiong, M., Huang, Z., Miao, L., & Fan, Y. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.06.001 · Cited by 28
Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis
Lin, C.-H., Lin, M., Kuo, Y.-W., & Ho, C. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.06.002 · Cited by 28
Xu, Q., Chen, X., Qian, D., Wang, Y., Meng, S., Liu, H., & Zhou, C. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12188 · Cited by 27
Hata, A., Katakami, N., Yoshioka, H., Takeshita, J., Tanaka, K., Masago, K., Fujita, S., Kaji, R., Imai, Y., Monden, K., et al. (2015) · PubMed · Cited by 26
Xing, P., Li, J., Shi, Y., & Zhang, X. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12049 · Cited by 7
Cited by
Yang, J. C. H., Kim, S.-W., Kim, D.-W., Lee, J.-S., Cho, B. C., Ahn, J.-S., Lee, D. H., Kim, T. M., Goldman, J. W., Natale, R. B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00457 · Cited by 395
Self-citationOsimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
Remon, J., Steuer, C. E., Ramalingam, S. S., & Felip, E. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx704 · Cited by 322
Leptomeningeal metastases in non-small-cell lung cancer
Cheng, H., & Perez-Soler, R. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30689-7 · Cited by 304
Li, Y. S., Jiang, B. Y., Yang, J. J., Zhang, X. C., Zhang, Z., Ye, J. Y., Zhong, W. Z., Tu, H. Y., Chen, H. J., Wang, Z., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy009 · Cited by 300
Self-citation
Metadata
- Authors
- Li, Y.-S., Jiang, B.-Y., Yang, J.-J., Tu, H.-Y., Zhou, Q., Guo, W.-B., Yan, H.-H., & Wu, Y.-L.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 11
- Issue
- 11
- Pages
- 1962-1969
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2513221119
- Cited by
- 312
- References
- 41
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.